The development marks an exciting new future for the brand, with more opportunities for visitors and exhibitors at the world’s nutraceutical event Informa Markets has announced that Vitafoods Europe, the world’s nutraceutical event, will move to its new home in Barcelona in 2025. After 26 hugely successful years in Geneva, the decision comes after extensive visitor and exhibitor feedback and exciting growth plans for the much-loved brand. With the global nutraceuticals market expected … [Read more...] about ¡Hola Barcelona!: Vitafoods Europe announces farewell to Geneva with relocation for 2025
Industry
Canvas8 and Givaudan Collaborate to Unveil FlavourVision® Trends Report: Illuminating the Future of Global Taste and Wellbeing
Included within the report, Canvas8 future-proofed insights from a bespoke panel of global thought leaders, from cyborg anthropologists to design strategists and philosophy professors Singapore (Monday, September 25th, 2023) – Leading behavioral insights firm, Canvas8, have announced their work with Givaudan, a global frontrunner in Fragrance & Beauty and Taste & Wellbeing, on their FlavourVision® trends report. This collaborative effort serves as a means of understanding and … [Read more...] about Canvas8 and Givaudan Collaborate to Unveil FlavourVision® Trends Report: Illuminating the Future of Global Taste and Wellbeing
Brenntag Specialties agrees to acquire Colony Gums, strengthening Life Science portfolio in North America
Brenntag [ISIN DE000A1DAHH0], the leader in chemicals and ingredients distribution, today announced an agreement to acquire Colony Gums, Inc., a US-based manufacturer of stabilizer blends and a blending services provider. The acquisition is expected to complement and expand Brenntag’s product portfolio and services in Life Sciences, primarily in nutrition. Michael Friede, CEO of Brenntag Specialties, commented: “Colony Gums will complement our existing business and enable us to serve … [Read more...] about Brenntag Specialties agrees to acquire Colony Gums, strengthening Life Science portfolio in North America
